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Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes 
chronic infections in the lungs of individuals with cystic fibrosis (CF). Like many 
Gram-negatives, P. aeruginosa produces outer membrane vesicles (MVs), which 
have been shown to package numerous factors including antimicrobial quinolone 
molecules, toxins, DNA, antibiotic resistance determinants, and cell-cell signaling 
molecules. The mechanism for the formation of MVs has not been fully elucidated. 
The Gram-negative outer membrane (OM) contains associated proteins, which 
anchor it to the peptidoglycan, and keep the OM stable. We hypothesized that 
peptidoglycan-associated outer membrane lipoproteins OprF, OprL, and OprI 
contribute to MV formation in P. aeruginosa. In this study, we quantified MVs 
harvested from oprF, oprL, and oprI mutants. The MV levels produced by the oprL 
and oprI mutants were not significantly different from those produced by the wild 
type; however, the oprF mutant showed a three-fold increase in MV production. 
These data indicate that OprF plays a significant role in anchoring the outer 



























































Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen 
typically found in water, soil, and vegetation, which can cause various chronic and 
acute infections (35). P. aeruginosa pathogenesis is tied to its production of virulence 
factors, enzymes that perform various functions including allowing adherence to host 
cells and causing cell and tissue damage (35; 25). P. aeruginosa regulates virulence 
factor production through quorum sensing (QS), a phenomenon that allows bacteria 
to monitor their cell-population density through a small molecule called an 
autoinducer, and to alter gene expression accordingly (33; 48). QS interference has 
been touted as a potential therapeutic approach, through the inhibition of 
autoinducer biosynthesis (48). 
A well-studied P. aeruginosa infection site is the lung of individuals with cystic 
fibrosis (CF) (35). CF is a hereditary disease that affects 1 in 2,500 Caucasian 
newborns (38). The symptoms of CF are due to a mutation in the CFTR gene, which 
encodes for an anion channel in exocrine epithelial cell membranes (38). This 
channel plays a role in mucus secretion, water permeability, and ATP transport. 
Individuals with CF are unable to effectively rid their lungs of sputum, and the 
thickened of mucus provides a nutrient-rich environment for bacteria (1).  >80% of 
adults with CF have been colonized by P. aeruginosa, and the average life 
expectancy is 37 years (1). Despite aggressive antibiotic treatment, these infections 
are very difficult to eradicate, due partly to the formation of P. aeruginosa biofilms 
within the CF lung (43). Biofilms, which are a polysaccharide and protein matrix 
excreted from cells attached to a surface, confer antimicrobial resistance to the 
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bacteria living within them (10; 45). Resistance to a wide range of antibiotics, 
including β-lactams and aminoglycosides, is a major problem affecting treatment of 
P. aeruginosa infections (35). Other clinical diseases caused by P. aeruginosa 
include: lower respiratory tract infections, skin infections, especially in burn wounds, 
urinary tract infections after prolonged in-dwelling urinary catheter usage, external 
otitis and chronic otitis media, corneal ulcers, bacteremia, and endocarditis (35).  
 
Bacterial Outer Membrane Vesicles  
As Gram-negative bacteria, P. aeruginosa have a bilayered inner membrane 
(IM), a gel-like periplasm, a thin layer of rigid peptidoglycan, and an outer membrane 
(OM). The OM is composed of protein, phospholipid, and lipopolysaccharide (LPS). 
MVs are spherical secretions 50-250 nm in diameter, which are composed of OM 
constituents and can also contain compounds found in the periplasm (6). MVs are 
associated with Gram-negatives growing planktonically, in biofilms, and in laboratory 
culture media (6). The ability of Gram-negatives to produce and excrete MVs was 
first identified over 40 years ago (25; 31; 32).  Chatterjee and Das (1967) reported 
on the “excretion of cell wall material” from Vibrio cholerae harvested during 
logarithmic growth, and their TEM images showed the V. cholerae membrane 
bulging out and pinching off (8).  
Recent reviews have discussed the myriad functions of MVs that have been 
identified thus far (25; 31; 32). The most-studied category of MVs is predatory MVs, 
which contain and concentrate factors which aid in competition with other bacterial 
species (25). The packaging of these molecules protects them from degradation and 
3 
 
host recognition (32). P. aeruginosa predatory MVs contain the autolysin 
peptidoglycan hydrolase, a periplasmic enzyme that is involved in peptidoglycan 
turnover, which causes the lysis of other species (20). These MVs break open on the 
cell wall surface of Gram-positives and hydrolyze the peptidoglycan. In Gram-
negatives, the MVs fuse with the OM, release their contents into the periplasm, and 
cause lysis of the peptidoglycan layer underneath (21; 6).  
MVs are involved in interspecies communication, or cell-cell signalling. In the 
case of P. aeruginosa, the QS autoinducer Pseudomonas Quinolone Signal (PQS) is 
packaged within MVs, allowing more efficient signaling than the wasteful alternative 
of free diffusion into the surrounding environment (29). This phenomenon may even 
extend to interdomain communication, for example in the hypothesized transfer of 
Nod factor between Rhizobium spp. and soybean roots (31).  
DNA transfer of plasmids within species has been shown in P. aeruginosa and 
in other Gram-negative species (22; 13; 20; 26; 40). This method could constitute a 
fourth mechanism of DNA transfer, in addition to the long-established mechanisms of 
transformation, conjugation, and transduction (40; 31). Enclosure within MVs affords 
the DNA protection from exonucleases in the environment, as well as enhancing the 
efficiency of DNA delivery and uptake (40; 31).  
MVs may be utilized in other types of transport. Since it has been found that 
the antibiotic gentamicin can enter MVs, the therapeutic delivery of antibiotics within 
MVs may be possible (6). It is proposed that through fusion, these g-MVs can deliver 
gentamicin to Pseudomonas species whose surfaces are otherwise impermeable to 
this antibiotic, and others of the aminoglycoside family. MVs may also be useful as 
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vaccine agents due to their species-specific antigenicity, though due to the 
endotoxicity of the LPS present on the MV surface, they would need to be orally 
administered (6).  
 
MVs in Bacterial Pathogenesis 
In general, pathogenic bacteria produce more MVs than nonpathogenic 
species (25). For example, Enterotoxigenic E. coli (ETEC) produces 10-fold more 
MVs than nonvirulent E. coli, and leukotoxic strains of Aggregatibacter 
actinomycetemcomitans, an oral commensal that is the causative agent of localized 
aggressive periodontitis, produces 25-fold more MVs than nonleukotoxic strains (23; 
25).  
P. aeruginosa can utilize MVs for establishing a colonization niche, as well as 
for modulating host responses (25). Virulence factors enclosed in P. aeruginosa MVs 
include phospholipase C, protease, hemolysin, and alkaline phosphatase, which all 
cause tissue damage (20; 35). Compounds that are recognized by immune 
pathways, such as LPS, lipoprotein, and outer membrane proteins are present on 
the surfaces of MVs (25). P. aeruginosa MVs have also been found to stimulate 
epithelial cells (e.g. in the lung) to secrete IL-8, a chemokine which recruits and 
activates neutrophils (2). The ability of bacteria to invade tissues is linked to MV 
binding to host cells (25).  
MVs can aid in the delivery of molecules within species, such as the transfer 
of β-lactamase from β-lactam-resistant strains of P. aeruginosa to nonresistant 
strains (9). The possible utility of excreting MVs to break down β-lactams serves as 
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an explanation for the lowered drug effectiveness in treating P. aeruginosa infections 
(6). Due to the presence of β-lactamases in MVs, β-lactam antibiotics are predicted 
to be inactivated upon entry into the vesicles, thus decreasing antibiotic resistance at 
the infection site.  
 
Mechanism of MV Formation 
Though much is now known about the contents of MVs, the mechanism of MV 
formation has not been fully elucidated. There are currently three proposed models, 
which are not necessarily mutually exclusive. The first predicts that localized OM 
detachment from the peptidoglycan is due to decreased lipoprotein linkage in certain 
areas (19; 31). Wensink and Witholt (1981) originally hypothesized that, since the 
OM expands faster than the peptidoglycan, it can detach, bulge out, and then 
invaginate form a vesicle (50). E. coli MVs contain very little bound OM lipoprotein, 
supporting their model. However, the overproduction of the OM relative to the 
peptidoglycan requires imbalanced growth, whereas MVs may also be produced 
during balanced growth, casting doubt on the validity of Wensink and Witholt’s 
hypothesis (55).  
The second model, proposed by Zhou, et al (1998), predicts that the products 
of cell wall turnover accumulate in the periplasm, exerting a turgor pressure on the 
OM, causing it to bulge and bleb out (55). A major building block of peptidoglycan, 
muramic acid, was detected in MVs, supporting the second model (55). 
The third model involves the disruption of the OM caused by changes in the 
LPS. Kadurugamuwa and Beveridge (1995) found that P. aeruginosa MVs are 
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composed mostly of negatively-charged B-band O-antigen even though the OM 
contains both B-band and the neutrally-charged A-band O-antigen (20). This 
evidence suggests that charge-charge repulsion of the LPS in the OM causes 
membrane instability (20; 6). An investigation by Mashburn and Whiteley (2005) 
supports this model by showing that PQS engages in ionic interactions with the 
Mg2+ and Ca2+ salt bridges that normally stabilize LPS charges (29). These 
localized areas of the OM then curve out and form MVs. In addition, these studies 
showed that PQS induces the formation of MVs, as well as its own self-packaging 
within MVs.  
 In addition to the role of PQS in causing OM instability the first model, which 
regards areas of OM with fewer peptidoglycan linkages, is also thought to be 
relevant for P. aeruginosa MV formation. A study done in Salmonella by Deatherage, 
et al (2009) provided quantitative evidence that conserved OM proteins are involved 
in OM-peptidoglycan and OM-peptidoglycan-IM interactions (11). These proteins 
help maintain membrane integrity, and play a part in inducing localized MV 
production through changes in their density and distribution during different cell 
growth stages.  
 
Peptidoglycan-associated Lipoproteins 
Peptidoglycan-associated lipoproteins were first discovered and characterized 
for the family Enterobacteriaceae, but initial studies showed that they did not exist in 
P. aeruginosa (28). However, using the same extraction methods at the lower 
temperature of 35°C, Mizuno and Kageyama (1979) found that OprF and OprL (then 
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called Protein F and H, respectively) were associated with peptidoglycan (34). These 
researchers were also the first to purify the proteins OprF (33,000 kDa), OprI (8,000 
kDa), and OprL (18,000 kDa) from P. aeruginosa. 
P. aeruginosa contains other major OM proteins: Iron repressible outer 
membrane proteins, receptors which bind iron complexed with siderophores during 
iron starvation conditions; OprC and OprE, which form channels for trisaccharides; 
esterase; OprP, a phosphate starvation induced phosphate-specific transport system 
porin; OprB, a porin involved in glucose uptake; OprD, a porin specific for the β-
lactam imipenem; OprG, which is putatively involved in iron uptake; and OprH, which 
blocks polycationic antibiotic uptake (17). Due to their presence on the cell surface, 
some Opr proteins are antigenic, as shown by the presence of Opr-specific 
antibodies in the sera of individuals with previous P. aeruginosa exposure (17).   
 
OprF 
The function of OprF has been much debated in the literature (17). OprF was 
originally characterized as a peptidoglycan-associated porin that forms water-filled 
channels when complexed as trimers (15; 4). To account for the apparent paradox of 
low OM permeability despite a high porin exclusion limit, the same studies 
concluded that only about 400 of the 200,000 OprF molecules present per cell 
actually form large channels (4; 36). These studies hypothesized that low OM 
permeability also accounts for increased antibiotic resistance in P. aeruginosa. Nicas 
and Hancock (1983) confirmed OprF porin function by showing that oprF mutants 
had lowered permeability (36). These mutants grew poorly without osmotic 
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stabilizers, such as NaCl, KCl, glucose, sucrose, or potassium succinate (36; 53).  
Since most OprF channels also appeared to exclude β-lactam antibiotics, Woodruff 
and Hancock (1988) tested the β-lactam uptake efficiency of OprF (52). Although 
they only found a low increase in β-lactam resistance for oprF mutants in 
comparison to the wild type, this finding did provide further support that OprF 
actually exists primarily as small channels.  
In the late 1980s, Nakae, et al published results suggesting that OprF was not 
a porin, thus initiating several years of controversy (54; 14). These conflicting reports 
were settled by Bellido, et al (1992), with their confirmation that OprF is a porin (3). 
Sugawara, et al (2006) conclusively resolved the paradox regarding why OprF forms 
a large channel but yet confers low permeability to the OM (47). They showed that 
OprF actually exists in two unique conformations: 98% of OprF molecules have a 
“closed” conformation, while only 2% are in an “open” conformation, corresponding 
to the large “small” to “large” channel ratio originally proposed by Hancock, et al (4; 
36; 52). 
The structural role of OprF was hypothesized based upon its association with 
the peptidoglycan (15; 14). Woodruff and Hancock (1989) investigated this role 
through comparisons of OprF function with that of its homologue, the E. coli major 
OM protein, OmpA (53). OmpA is a pore-forming protein which exists as an active 
monomer (46). Woodruff and Hancock’s initial evidence included the shorter and 
rounder cell morphology of oprF mutants (53). They also illustrated that OprF cross-
reacts with OmpA, and that oprF can complement back wild type morphology in 
ompA mutants. Rawling, et al (1998) showed that the C-terminal 180 amino acids of 
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OprF are homologous to the C-terminal 168 amino acids of OmpA (39). While the 
first 154-164 amino acids, which constitute the OprF C-terminal domain, are 
necessary for the protein’s stable expression in the OM, association with the 
peptidoglycan requires ≥ 215 amino acids (39). Sugawara et al (2006) have 
proposed that the role of the major function of OprF is actually in OM stabilization, 
and that its role as a porin is negligible (47).  
 
OprL 
OprL has covalently bound fatty acyl chains and is strongly but noncovalently 
associated with the peptidoglycan (17). Koebnik, et al (1995) proposed that an α-
helical motif at the C-terminus interacts with the peptidoglycan (24). OprL is a 
conserved protein in related Pseudomonads (17). The 504 bp open reading frame 
(ORF) shares 96% sequence homology with the P. putida PAL, and 57-64% 
homology with other PALs, especially at the C-terminal end (27). OprL is required for 
maintaining OM permeability in P. putida, as oprL mutants show sensitivity to the 
presence of SDS, deoxycholate, and EDTA in the medium (41). E. coli pal mutants 
also show increased sensitivity to drugs and detergents, as well as an increased 
production of MVs (5). Similar to the oprF mutant of P. aeruginosa, the P. putida oprL 
mutant also does not grow on low osmolarity medium (36; Rodriguez-Herva 1996). 
The cell morphology of the P. putida oprL null mutant also demonstrates a wavy OM 
(41). This evidence all suggests that P. aeruginosa OprL and its homologues have a 







Mizuno and Kageyama (1979) isolated OprI from both the OM and the 
peptidoglycan (34). They provided evidence that OprI is covalently bound to 
peptidoglycan, but Hancock (1981) found that whether OprI associates covalently or 
noncovalently with peptidoglycan depends on the strain; in P. aeruginosa, OprI is of 
the latter category (16). OprI is a highly abundant protein that is homologous to the 
Braun lipoprotein (Lpp), an E. coli OM structural component (7; 34). While Braun's 
lipoprotein has three fatty acid residues, OprI only has one, hexadecanoic acid (34). 
The oprI gene, which is conserved among fluorescent Pseudomonads, was recently 




This project concerns the effect of peptidoglycan-associated lipoprotein 
“anchors” in the OM on MV production. I hypothesize that the absence of OprF, 
OprL, and OprI in the OM leads to loss of OM integrity, and the increased production 
of MVs. To test the validity of this MV formation model in P. aeruginosa, I generated 
mutant strains in which the genes encoding the proteins OprF, OprL, and OprI were 






Fig. 1: A. The outer membrane, peptidoglycan, periplasm, and inner membrane of P. aeruginosa. The 
lipoproteins OprF, OprL, and OprI are shown embedded in the OM and associating with the 
underlying peptidoglycan. B. Membrane vesicles form as sections of the OM bulge out and pinch off. I 
hypothesize that, in the absence of anchorage by peptidoglycan-associated lipoproteins, there is an 











Creation of mutants 
Sequences for oprF, oprL and oprI in the Pseudomonas aeruginosa strain 
PA14 were obtained from the Pseudomonas Genome Project. To cleanly delete oprL 
and oprI from the PA14 chromosome, knockout constructs were first made by PCR-
amplifying two 1 kb regions that flank the genes of interest. Four primers were 
designed for each construct, with BamHI sites on the outermost two primers, P1 and 
P4, and a region of complementarity between the inner primers, P2 and P3.  
oprL primers 
P1: 5’ CCGGATCCGAGAAGCTCACCGGTATCAAG 3’ 
P2: 5’ GTGCTTGGGCATAACGACTTC CATGTAACT 
CCTAATGAACCC 3’ 
P3: 5’ GAAGTCGTTATGCCCAAGCAC 3’ 
P4: 5’ CAGGATCCGTACTGGGAAATGACCTGCTG 3’ 
 
oprI primers 
P1: 5’ CCGGATCCAGGTACTCCAGGTTCAGCCAC 3’ 
P2: 5’ GTTTTCAACAGGTCGTGAGACCGGTGGACA 
TTTCCATAACAGCAATC 3’ 
P3: 5’ GGTCTCACGACCTGTTGAAAAC 3’ 
P4: 5’ CCGATCCAGGTGATCAAGGCCAAGTAC 3’ 
 
 
Table 1: Primers for the construction of the oprL and oprI knockout constructs. 
 
The two PCR products for each knockout construct were “sewn” together in a 
second PCR reaction using the primers P1 and P4.  
The resulting 2 kb knockout constructs were TA-cloned into a TOPO TA vector 
(Invitrogen), and digested using the restriction enzyme BamHI for oprL∆, and EcoRI 
for oprI∆. The constructs were ligated into the plasmid pEX18TC, which carries a 
tetracycline resistance cassette, tet, and the Bacilus subtilis gene, sacB, which 
13 
 
encodes for a levansucrase (18). The vector was first transformed into SM10 
Escherichia coli and then transferred into PA14 via biparental conjugation. pEX18TC 
contains an oriT site, while SM10 carries the mobilization factors mob and tra, which 
are all necessary for conjugation to occur. Since pEX18TC is a suicide vector in P. 
aeruginosa, chromosomal integration of the plasmid was selected for using 
tetracycline. The integration event was verified with PCR using primers designed to 
amplify the sacB open reading frame (5-sacB: 5’ GCAACAGTATTAACCTTTAC 3’ 
and 3-sacB: 5’ GTTAACTGTTAATTGTCCTTG 3’).  
Resolution of the merodiploid state, which resulted in the deletion of the wild 
type gene, was positively selected for by plating culture dilutions onto Luria Bertani 
(LB) agar supplemented with 5% sucrose. True mutants no longer contained sacB, 
which has lethal effects on the cell in the presence of sucrose. Colonies were then 
patched onto LB agar supplemented with 5% sucrose and LB agar containing 50 
µg/mL tetracycline in order to select for sucrose-tolerant, tetracycline-sensitive 
colonies. Negative selection using tetracycline was necessary due to the high sacB 
mutation rate. Clean deletions of oprL and oprI were verified by PCR using primers 
for the regions externally flanking the knockout constructs. The resultant PCR 














oprL-out-flank-5: 5’ GGAAGGCAGTTGGCGTCAAC 3’ 
oprL-out-flank-3: 5’ GTGACGACTGAACAGGTCGTC 3’ 
oprL-internal-5: 5’ GCT ACA CCA ACT TCC AGA TC 3’ 
oprL-internal-3: 5’ GGA AATCCGACGGTCGAGGTC 3’ 
 
oprI∆ verification 
oprI-out–flank-5: 5’ GCAACTGCCGATCCATTCCTC 3’ 
oprI-out-flank-3: 5’ CCGTTGTCTCACTGTCTTTCG 3’ 
oprI-internal-5: 5’ CGGCTAATCAAGTTAACCGG 3’ 
oprI-internal-3: 5’ GTGCGTATCATCAACGAGCC 3’ 
 
Table 2: Outer flanking primers used for mutant verification. 
 
To complement the oprL∆ and oprI∆ mutants, oprL and oprI were ligated into 
the arabinose-inducible pJN105 plasmid using XbaI and EcoRI digest sites. Empty 
pJN105 plasmid was electroporated into PA14 and each mutant strain as a control. 





Fig. 2. External regions flanking the genes of interest were amplified and ligated together using PCR 
to create the knockout construct. The construct was cloned into pEX18TC. The vector was transferred 
into PA14, where it recombined into the chromosome. Clean deletions of the wild type genes were 




A clean deletion of oprF was attempted but was unsuccessful.  While the 
pEX18TC-oprF∆ merodiploid was obtained, no knockouts could be generated. In 
order to generate the mutant, the growth conditions were modified by either 
supplementing LB with NaCL, or using Mueller Hinton broth. Over sixty colonies, 
which grew on LB (or Mueller Hinton) agar supplemented with 5% sucrose but not 
on LB (or Mueller Hinton) agar containing 50 µg/mL tetracycline, were tested. PCR 
using primers for regions flanking the knockout constructs (oprF-out-flank-5: 5’ 
GTTGGCCTCGAATACGCGAAC 3’ and oprF-out-flank-3: 5’ 
GTTGAAAGAACTCTGGCTTAC 3’) showed that these strains had all crossed back 
to wild type.  
Instead, a PA14 oprF- strain was taken from the Non-Redundant Transposon 
Insertion Mutant Set from the Ausubel Laboratory at Harvard Medical School. The 
mutant contains a MAR2xT7 transposon insertion, which includes a gentamicin-
resistance cassette. Since the insertion is upstream of amino acid 215, the resulting 
truncated protein cannot associate with the peptidoglycan (39), and thus should not 
be able to tether the OM to the peptidoglycan. 
To complement oprF-, the ApR/CbR plasmid pEX1.8, which has an IPTG-
inducible ptac promoter (a combination of the tryptophan and lactose promoters) 
was used. oprF  was TA cloned into the  pGEM T-easy vector (Promega) and the 
gene was digested out using a PstI cut site from the vector backbone, along with a 
HindIII site that was added onto the reverse primer used to PCR-amplify the gene (5’ 
CCCAAGCTTTTTTCCTTAGAGGCTCA 3’). These sites corresponded with the 5’ 
PstI and 3’ HindIII sites downstream of the ptac promoter in pEX1.8. The insert was 
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ligated into pEX1.8, and the vector was electroporated into oprF-. Empty pEX1.8 
plasmid was electroporated into both PA14 and oprF- as a control. The vector was 
induced using 500 µM IPTG. 
The doubling time for oprF- + pEX1.8 in BHI containing 50 µg/mL carbenicillin 
was 42 min, as compared to 30 min for both wild type + pEX1.8 and the mutant 
complemented. The doubling time for oprL∆ + pJN105 in BHI containing 25 µg/mL 
gentamicin was 52 min as compared to 37 min for both wild type + pJN105 and the 
mutant complemented.  
 
Preparation of Membrane Vesicles 
The strains were grown overnight in 25 mL Brain Heart Infusion (BHI) broth at 
37°C shaking with the appropriate antibiotics (25 µg/mL gentamicin for strains 
containing pJN105, and 50 µg/mL carbenicillin for strains containing pEX1.8). 
Stationary stage cells were pelleted by centrifugation at 5000 xg for 15 min at room 
temperature. The supernatant containing the MVs was filtered through a .45 µM pore 
syringe filter (Pall), and 3 mL were removed for lipid quantification. Vesicles from the 
remaining filtered supernatant were pelleted by ultracentrifugation (Beckman-Coulter 
Optima L-100K) at 60,000 xg for 1 hr 6 min at 15°C, along with a sterile BHI control 
of equal volume. The supernatant was removed and the vesicle pellet was 
resuspended in MV buffer (1.514 g Tris, .073 g NaCl, .030g MgSO4, suspended in 
250 mL deionized distilled water at a pH of 7.2-7.5). The resuspended pellet was 
then spun again in the ultracentrifuge at 60,000 xg for 1 hr 6 min at 15°C. The pellet 
was then resuspended in 500 µL MV buffer and filtered through a 300K Nanosep 
18 
 
centrifugal deivce (Pall Life Sciences) using a tabletop centrifuge, at 8000 xg for 5 
min. Vesicles were resuspended in a 50 µL final volume of MV buffer.  
 
Lipid Quantification Assays 
Lipid assays were performed to quantitate the amount of lipid harvested from 
the MV preps. The assay was adapted from a method by Stewart (1979) (44). The 
color change is produced by phospholipids complexing with ammonium 
ferrothiocyanate. The colored complex partitions into the chloroform phase and is 
easily removed for an absorbance reading, since ammonium ferrothiocyanate is 
insoluble in chloroform, while lipid is soluble in chloroform.  
The protocol is as follows: The 3 mL of filtered supernatant taken from the 
original filtered culture was transferred into a 20 mL glass vial. 3 mL chloroform was 
added to each sample, which was vortexed. Samples were centrifuged at 2000 xg 
for 2 min. The bottom chloroform layer (about 2400 µL) was transferred to a new 20 
mL glass vial and 2400 µL ammonium ferrothiocyanate (stock solution of 27.03 g 
FeCl3 6H20 and 30.4 g NH4SCN dissolved in 1L deionized distilled water) was 
added, and the sample was vortexed. The sample was centrifuged at 2000 xg for 5 
min. The bottom layer (about 1800 µL) was moved into a 4 mL glass vial and dried 
down under nitrogen. The dried sample was resuspended in 1000 µL chloroform and 
its absorbence was read at 470 nm. A standard curve was calculated using a 1 





Fig. 3: Steps preceding lipid quantification. Cultures are pelleted by centrifugation, and the filtered 
supernatant is used in the lipid assay.  
 
Protein Quantification Assays 
Total protein from vesicle preparations was quantified using the Coomasie 
Plus (Bradford) Assay Kit (Thermo Scientific), using a 25 µL aliquot of the MV prep. 
Protein concentration was determined by the color change caused by Coomassie 
Blue binding to proteins in the sample. Absorbance was read spectrophotometrically 
at a wavelength of 595 nm. A standard curve was calculated using dilutions of a 2 




Fig. 4: Steps preceding protein quantification. Cultures are pelleted by centrifugation and supernatant 







































Vesicles were fixed with 3% glutaraldehyde and stored at 4°C for Transmitting 
Electron Microscope (TEM) imaging. 400 nm copper mesh grids were coated with 
Formvar and allowed them to dry overnight. For negative staining, fixed vesicles 
were placed on the grids with a 1:1 ratio of 2% uranyl acetate. Images were 
visualized with a FEI Tecnai TEM, equipped with an AMT Advantage HR 1kx1k 




















The concentrations of protein (µm/mL) and lipid (mg/mL) were determined 
from standard curves performed on the same day as the assays. Normalized values 
were obtained by dividing total protein and lipid over the OD600 of the starting 
























         
 
Fig. 5: A. Lipid quantification of MV preps for wild type, oprF mutant, and oprF mutant complemented 
with the wild type gene. B. Lipid quantification of MV preps for wild type, oprL mutant, and oprL 
mutant complemented with the wild type gene. C. Lipid quantification of MV preps for wild type, oprI 


















       
 
Fig. 6: A. Protein quantification of MV preps for wild type, oprF mutant, and oprF mutant 
complemented with the wild type gene. B. Protein quantification of MV preps for wild type, oprL 
mutant, and oprL mutant complemented with the wild type gene. C. Protein quantification of MV preps 
for wild type, oprI mutant, and oprI mutant complemented with the wild type gene.  
 
Error bars represent the standard error of the mean.  
 
I hypothesized that the OM proteins OprF, OprL, and OprI act as anchors, 
tethering the OM to the peptidoglycan. The absence of these proteins causes 
increased MV production as the destabilized OM blebs off. In support of the model, 
the data from both lipid and protein quantification assays show a three-fold increase 
in MV production of the oprF mutant compared to the wild type.  Lipid quantification 
assays indicate that there is no significant difference in MV production between the 
oprL and oprI mutants and the wild type.  
 
Preliminary TEM images show that the average diameter of MVs produced by 
oprF- is 72 nm. Diameters were measured using ImageJ, with n = 67. These MVs 
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fall within the reported range of 50 – 150 nm for wild type P. aeruginosa (20).  
 
 









The data show that Pseudomonas aeruginosa oprF mutants produce three-
fold more membrane vesicles than the wild type. These results further support the 
role of OprF in providing stability to the OM, through its association with the 
underlying peptidoglycan. OprL and OprI do not appear to have a major role as 
membrane anchors. The difference between these two proteins and OprF may be 
due to the latter’s larger size and greater frequency within the OM.  
These results give weight to the first model of MV formation, which 
hypothesizes that areas of OM containing fewer protein connections to the 
underlying peptidoglycan undergo increased MV formation. The utility of the third 
model, which proposes that changes in the LPS cause the ensuing destabilization of 
the OM, has already been shown for P. aeruginosa (29). The results shown in this 
study support for the conclusion made by Deatherage, et al (2009) that conserved 
OM proteins act as potentially unifying factors in MV release (11). Here, the relevant 
P. aeruginosa OM proteins have been tested to ascertain the validity of that 
assertion.  
In a broader view, these studies on particular OM-peptidoglycan connecting 
proteins provide more background for P. aeruginosa MV formation. The ability of P. 
aeruginosa to release MVs is widely-studied phenomenon, as this process shows 
how these bacteria are able to “talk to its friends and attack its enemies,” as one 
reviewer so deftly put it (51).  
The data presented here also shed more light on the role of OprF in 
stabilizing the OM, which has been speculated upon since the protein’s discovery in 
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the 1970s. Interest in the structural role of OprF has been renewed by more recent 
investigations that concentrate on the importance of the protein for structuring the 
OM, rather than in regulating OM permeability. 
 
My future work will include the construction of double mutants (oprF-oprL∆, 
oprF-oprI∆, and oprL∆oprI∆), and determining MV production for each. It is expected 
that the oprF-oprL∆ and oprF-oprI∆ mutants will show increased MV production as 
compared to the wild type, following the findings for the oprF- single mutant. It would 
also be interesting to examine the effects an oprL∆oprI∆ double mutant would have 
on MV production, since the oprL∆ and oprI∆ single mutants do not have a 
significant effect. 
Further TEM imaging will be performed in order to compare the diameters of 
MVs produced by each mutant to those produced by the wild type. This analysis will 
show whether MVs produced by mutants differ in size, and whether increased MV 
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